Center Laboratories, Inc. (4123.TWO) Stock

About Center Laboratories, Inc.

Center Laboratories, Inc. operates as a Taiwanese pharmaceutical enterprise, with its primary focus lying in the manufacturing and distribution of various medical products across Taiwan. Beyond its core drug operations, the firm is heavily invested in the research and development of both small molecule therapeutics and biologics, including proteins and antibodies. Additionally, its extensive portfolio encompasses pharmaceutical CDMO services, medical devices, nutritional health products, agribiotechnology initiatives, advanced stem cell and immune cell therapies, and even strategic ventures in industry investment funds and venture capital. Founded in 1959, Center Laboratories maintains its headquarters in Taipei, Taiwan.

Center Laboratories, Inc. is led by CEO Su-Chi Wang, employs 182 people, headquartered in Taipei, TW, publicly traded since 2007.

over the past 52 weeks the stock has ranged between $29.35 and $48.96, and currently trades 38.9% below its 52-week high.

Official website: www.centerlab.com.tw

Center Laboratories, Inc. (4123.TWO) — frequently asked questions